This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Morten Lundh, Ph.D.
Director, Drug Discovery Innovation at Gubra A/S
Speaker

Profile

Morten Lundh is a Director of Drug Discovery at Gubra. He is leading a team which drives innovation around drug discovery and related technologies. He has also been leading several internal drug discovery projects from hit identification to lead optimization. Morten received a PhD in Molecular Biology in 2013 from University of Copenhagen.

Agenda Sessions

  • Development of GUBamy, A Clinical Stage Long-acting Amylin Analogue Formulated at Neutral pH, Using StreaMLine - A ML-driven Peptide Drug Discovery Platform

    10:45